Horváth IG - Search Results

1

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.

Aradi D, Rideg O, Vorobcsuk A, Magyarlaki T, Magyari B, Kónyi A, Pintér T, Horváth IG, Komócsi A. Aradi D, et al. Among authors: horvath ig. Eur J Clin Invest. 2012 Apr;42(4):384-92. doi: 10.1111/j.1365-2362.2011.02594.x. Epub 2011 Sep 9. Eur J Clin Invest. 2012. PMID: 21902692 Clinical Trial.

2

Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity.

Aradi D, Vorobcsuk A, Lenkey Z, Horváth IG, Komócsi A. Aradi D, et al. Among authors: horvath ig. Platelets. 2010;21(1):1-10. doi: 10.3109/09537100903391015. Platelets. 2010. PMID: 19929306

3

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL. Aradi D, et al. Among authors: horvath ig. Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Am Heart J. 2010. PMID: 20826265 Review.

4

Outcomes of patients receiving clopidogrel prior to cardiac surgery.

Vorobcsuk A, Aradi D, Farkasfalvi K, Horváth IG, Komócsi A. Vorobcsuk A, et al. Among authors: horvath ig. Int J Cardiol. 2012 Apr 5;156(1):34-40. doi: 10.1016/j.ijcard.2010.10.034. Epub 2010 Nov 26. Int J Cardiol. 2012. PMID: 21112646 Review.

5

Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.

Aradi D, Tornyos A, Pintér T, Vorobcsuk A, Kónyi A, Faluközy J, Veress G, Magyari B, Horváth IG, Komócsi A. Aradi D, et al. Among authors: horvath ig. J Am Coll Cardiol. 2014 Mar 25;63(11):1061-70. doi: 10.1016/j.jacc.2013.12.023. Epub 2014 Jan 30. J Am Coll Cardiol. 2014. PMID: 24486281 Free article.

6

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity.

Tornyos A, Aradi D, Horváth IG, Kónyi A, Magyari B, Pintér T, Vorobcsuk A, Tornyos D, Komócsi A. Tornyos A, et al. Among authors: horvath ig. PLoS One. 2017 Dec 7;12(12):e0188493. doi: 10.1371/journal.pone.0188493. eCollection 2017. PLoS One. 2017. PMID: 29216314 Free PMC article.

7

Thienopyridine therapy influences late outcome after coronary stent implantation.

Aradi D, Kónyi A, Pálinkás L, Berki T, Pintér T, Tahin T, Horváth I, Papp L, Komócsi A. Aradi D, et al. Angiology. 2008 Apr-May;59(2):172-8. doi: 10.1177/0003319707304572. Epub 2008 Apr 2. Angiology. 2008. PMID: 18388039 Clinical Trial.

8

Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis.

Vorobcsuk A, Kónyi A, Aradi D, Horváth IG, Ungi I, Louvard Y, Komócsi A. Vorobcsuk A, et al. Among authors: horvath ig. Am Heart J. 2009 Nov;158(5):814-21. doi: 10.1016/j.ahj.2009.08.022. Am Heart J. 2009. PMID: 19853703

9

Raising the loading dose of clopidogrel: aiming at the proper target?

Komócsi A, Pintér T, Horváth IG. Komócsi A, et al. Among authors: horvath ig. Eur Heart J. 2005 Apr;26(7):740; author reply 740-1. doi: 10.1093/eurheartj/ehi157. Epub 2005 Feb 16. Eur Heart J. 2005. PMID: 15716286 No abstract available.

10

Variability in response to clopidogrel: where is the threshold for 'low response'?

Dániel A, Pintér T, Horváth IG, Komócsi A. Dániel A, et al. Among authors: horvath ig. Eur Heart J. 2007 Feb;28(4):515-6; author reply 516. doi: 10.1093/eurheartj/ehl499. Epub 2007 Feb 8. Eur Heart J. 2007. PMID: 17289747 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page